These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
9 results:

  • 1. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
    Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
    [No Abstract]    [Full Text] [Related]  

  • 2. A high density of PD-L1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer.
    Kuo YT; Liao CK; Chen TC; Lai CC; Chiang SF; Chiang JM
    Medicine (Baltimore); 2022 Jan; 101(3):e28573. PubMed ID: 35060518
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
    Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
    [No Abstract]    [Full Text] [Related]  

  • 4. The impact of microsatellite stability status in colorectal cancer.
    Gupta R; Sinha S; Paul RN
    Curr Probl Cancer; 2018 Nov; 42(6):548-559. PubMed ID: 30119911
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Association of programmed cell death 1 (pdcd1) gene polymorphisms with colorectal cancer among Han Chinese population].
    Zhao Y; Mao Z; Pang H; Zhao X; Zhang S; Gao Z; Yang Y; Fang T; Ma Q; Ma X; Wang Y; Zhang J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):219-223. PubMed ID: 29652996
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Implications of the tumor immune microenvironment for staging and therapeutics.
    Taube JM; Galon J; Sholl LM; Rodig SJ; Cottrell TR; Giraldo NA; Baras AS; Patel SS; Anders RA; Rimm DL; Cimino-Mathews A
    Mod Pathol; 2018 Feb; 31(2):214-234. PubMed ID: 29192647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.
    Bethmann D; Feng Z; Fox BA
    Curr Opin Immunol; 2017 Apr; 45():60-72. PubMed ID: 28222333
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.
    Schaefer T; Satzger I; Gutzmer R
    Medicine (Baltimore); 2017 Jan; 96(1):e5753. PubMed ID: 28072717
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrative Analyses of colorectal cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
    Mlecnik B; Bindea G; Angell HK; Maby P; Angelova M; Tougeron D; Church SE; Lafontaine L; Fischer M; Fredriksen T; Sasso M; Bilocq AM; Kirilovsky A; Obenauf AC; Hamieh M; Berger A; Bruneval P; Tuech JJ; Sabourin JC; Le Pessot F; Mauillon J; Rafii A; Laurent-Puig P; Speicher MR; Trajanoski Z; Michel P; Sesboüe R; Frebourg T; Pagès F; Valge-Archer V; Latouche JB; Galon J
    Immunity; 2016 Mar; 44(3):698-711. PubMed ID: 26982367
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.